OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Psychiatry is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	773
Error in Results	538
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	448
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	409
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	300
Assumptions and Limitations of the Synthetic Control Method	258
Managerial and Organizational Challenges in the Age of AI	249
An Opportunity to Advance Cannabis Science—DEA Rescheduling	238
JAMA Psychiatry	234
The Reliability of Traumatic and Adverse Experiences	211
Potential Lessons for DSM From Contemporary Philosophy of Science	198
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	197
Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings	196
Race and Ethnicity of Editorial Board Members and Editors as an Indicator of Structural Racism in Psychiatry and Neuroscience Journals	185
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	183
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	182
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	178
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	159
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA	158
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	151
JAMA Psychiatry	149
Diagnosing and Treating ADHD in Adults	147
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	143
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy	141
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	134

Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression	130
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	126
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	118
JAMA Psychiatry	117
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness	113
JAMA Network Call for Papers on Health and the 2024 US Election	110
Errors in Figures 1 and 2	109
Living Alone and Drug Overdose Deaths in the US	109
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	108
JAMA Psychiatry	107
Addiction Medicine Physicians and Medicinal Cannabinoids	104
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	103
Searching the Brain for the Cause of Psychosis	103
Hyperalgesia in Patients With a History of Opioid Use Disorder	98
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older	95
Perinatal Mental Health Outcomes Following Natural Disasters	94
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	93
The Role of Energy Homeostasis in Depression Pathophysiology and Its Heterogeneity	92
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	91
Error in Byline	90
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction	88
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression	87
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth	86
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	86
JAMA Psychiatry	84
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?	83
JAMA Psychiatry—The Year in Review, 2021	82
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity	81
Associating Violence With Schizophrenia—Risks and Biases—Reply	81
Errors in Figures 3, 4, and 5	81
Expanding Current Approaches to Solve the Opioid Crisis	78
War Exposure and DNA Methylation in Syrian Refugee Children and Adolescents	74
Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study	74
Trends in Outpatient Psychotherapy Among Adults in the US	74
JAMA Psychiatry	73
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	73
Limitations for Assessing Optimism and Physical Functioning in Women—Reply	73
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply	72
Psychosis Spectrum Symptoms Before and After Adolescent Cannabis Use Initiation	71
Evaluation of a Model to Target High-risk Psychiatric Inpatients for an Intensive Postdischarge Suicide Prevention Intervention	71
Physician Suicide and Associated Features—What Defines a Physician?	69
Stratified Care vs Stepped Care for Depression	67
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder	67
Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder	67